Maternal Gut Virome Linked to Preterm Birth Risk

New Nature study finds maternal gut virome disruption precedes preterm birth, with viral signatures improving prediction of early delivery.

Maternal Gut Virome Linked to Preterm Birth Risk

A new study published in Nature has found that disruptions to the maternal gut virome — the viral component of the gut microbiome — precede preterm birth and are linked to measurable metabolic changes in pregnancy. Researchers used longitudinal multi-omics analyses to track viral signatures in expectant mothers, finding that these markers could improve the prediction of preterm birth before clinical symptoms emerge.

Why This Matters

Preterm birth, defined as delivery before 37 weeks of gestation, remains one of the leading causes of neonatal mortality and long-term developmental complications worldwide. Growing evidence in gut health research suggests that the gut microbiome — including its lesser-studied viral populations — plays a critical role in systemic health outcomes. The virome, which comprises bacteriophages and other viral entities residing in the gut, has until now received far less scientific attention than bacterial microbiome components, despite its potential influence on immune and metabolic function during pregnancy.

Viral Gut Signatures Found Before Preterm Birth Onset

According to the research team, gut virome disruption was observed in participants who later experienced preterm birth, and these changes were detectable in advance of delivery. The study found that virome alterations were closely associated with metabolic features, suggesting the gut-brain and gut-body axis may be implicated in the biological pathways connecting viral gut ecology to pregnancy outcomes. Researchers report that incorporating viral signatures into predictive models improved the accuracy of preterm birth forecasting, positioning the virome as a potential therapeutic or diagnostic target.

What This Means for Gut Health Research in the UK

For researchers and clinicians interested in gut health UK-wide, this study adds an important dimension to ongoing microbiome UK investigations. Institutions such as King's College London and the University of Cambridge have been advancing microbiome science in pregnancy, and findings of this nature are likely to inform future UK Biobank and British Gut Project research priorities. The study suggests that monitoring gut virome dynamics during pregnancy could one day complement existing NHS antenatal screening pathways.

The research highlights the virome as a promising but underexplored area of gut health science. As scientists work to improve gut health naturally through dietary and clinical interventions, understanding how viral gut communities shift during pregnancy — and how those shifts relate to metabolic and birth outcomes — could open new avenues for early intervention. Further clinical validation in diverse UK and global populations will be essential before virome-based screening enters routine practice.

You might also like

96 Bacterial Strains. Two Shots a Day.

GOODIE is an award-winning fermented drink with 96 live bacterial strains — more than any yogurt or kombucha — never pasteurised, clinically tested, and 8 in 10 users felt less bloating within 14 days. Curious?

Find out more →